Rising drug shortages are creating new compliance pressure across pharmaceutical supply chains and healthcare systems. In a recent discussion, Valerie Bandy from Tecsys warned that fragmented inventory visibility, delayed escalation, and growing reliance on manual workarounds are exposing hidden weaknesses
